Intas develops COVID-19 Hyperimmune Globulin, gets human trial approval

Intas Pharmaceuticals Ltd., the largest supplier by volume of generic medicines to the UK NHS, is collaborating on a World Health Organisation endorsed study into the prevention of COVID-19 infection using hydroxychloroquine, a drug that may have an
X